Catharina Gerhards
Overview
Explore the profile of Catharina Gerhards including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerhards C, Teufel A, Gerigk M, French M, Antoni C, Ebert M, et al.
Nutrition
. 2024 Apr;
124:112447.
PMID: 38669827
Background: To study the relationship of Vitamin D with innate and adaptive immune response parameters in chronic hepatitis B and C patients. Methods: The laboratory data between January 1, 2013...
2.
Gerhards C, Steingass M, Heininger A, Lange B, Hetjens M, Gerigk M, et al.
Vaccines (Basel)
. 2024 Feb;
12(2).
PMID: 38400146
Background: The aim of the rapid introduction of vaccines during the COVID-19 pandemic was a reduction in SARS-CoV-2 transmission and a less frequent occurrence of severe COVID-19 courses. Thus, we...
3.
Gerhards C, Evliyaoglu O, Ast V, Neumaier M
Clin Chem Lab Med
. 2023 Jul;
62(2):e37-e39.
PMID: 37522425
No abstract available.
4.
Gerhards C, Haselmann V, Schaible S, Ast V, Kittel M, Thiel M, et al.
Microorganisms
. 2023 Jul;
11(7).
PMID: 37512912
Background: Severe courses and high hospitalization rates were ubiquitous during the first pandemic SARS-CoV-2 waves. Thus, we aimed to examine whether integrative diagnostics may aid in identifying vulnerable patients using...
5.
Gerhards C, Thiaucourt M, Hetjens M, Haselmann V, Neumaier M, Kittel M
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992285
Background: Longitudinal humoral SARS-CoV-2 (severe acute respiratory syndrome coronavirus type 2) immunity for up to 15 months due to vaccination, the efficacy of vaccination strategies (homologous, vector-vector versus heterologous, vector-mRNA),...
6.
Gerhards C, Kittel M, Ast V, Bugert P, Froelich M, Hetjens M, et al.
Viruses
. 2023 Feb;
15(2).
PMID: 36851668
Background: The duration of anti-SARS-CoV-2-antibody detectability up to 12 months was examined in individuals after either single convalescence or convalescence and vaccination. Moreover, variables that might influence an anti-RBD/S1 antibody...
7.
Ozbay Kurt F, Lepper A, Gerhards C, Roemer M, Lasser S, Arkhypov I, et al.
Front Immunol
. 2022 Oct;
13:1012526.
PMID: 36311732
A gradual decay in humoral and cellular immune responses over time upon SAR1S-CoV-2 vaccination may cause a lack of protective immunity. We conducted a longitudinal analysis of antibodies, T cells,...
8.
Jungbauer F, Gerhards C, Thiaucourt M, Behnes M, Rotter N, Schell A, et al.
Life (Basel)
. 2022 Jul;
12(7).
PMID: 35888058
Sudden onset of anosmia is a phenomenon often associated with developing COVID-19 disease and has even been described as an initial isolated symptom in individual cases. In this case-control study,...
9.
Rotterdam J, Thiaucourt M, Weiss C, Schwaab J, Reiter A, Kreil S, et al.
Ann Hematol
. 2022 May;
101(8):1825-1834.
PMID: 35597847
COVID-19 in patients with hematological diseases is associated with a high mortality. Moreover, preventive vaccination demonstrated reduced efficacy and the knowledge on influencing factors is limited. In this single-center study,...
10.
Thiaucourt M, Gerhards C, Kittel M, Ast V, Santhanam N, Klawonn F, et al.
Clin Lab
. 2021 Dec;
67(12).
PMID: 34910436
Background: Despite increasing COVID-19 infection rates, low overall prevalence resulting in a poor positive predictive value (PPV) of serological tests requires strategies to increase specificity. We therefore investigated a dual...